학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 25건 | 목록 1~10
Academic Journal
Wesley JD; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, Washington, USA.; Pagni PP; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, Washington, USA.; Bergholdt R; Type 1 Diabetes & Functional Insulins, Clinical Drug Development.; Kreiner FF; Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark.; von Herrath M; Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark.; Type 1 Diabetes Center, The La Jolla Institute for Immunology, La Jolla, California, USA.
Publisher: Lippincott, Williams & Wilkins Country of Publication: England NLM ID: 101308636 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-2978 (Electronic) Linking ISSN: 1752296X NLM ISO Abbreviation: Curr Opin Endocrinol Diabetes Obes Subsets: MEDLINE
Academic Journal
Pagni PP; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Chaplin J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Wijaranakula M; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Wesley JD; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Granger J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Cracraft J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; O'Brien C; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Perdue N; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Kumar V; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Li S; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Ratliff SS; La Jolla Institute for Immunology, La Jolla, CA, USA.; Roach A; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Misquith A; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Chan CL; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Coppieters K; Project and Alliance Management, Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.; von Herrath M; La Jolla Institute for Immunology, La Jolla, CA, USA.; Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark.
Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
Academic Journal
Pagni PP; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Chaplin J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Wijaranakula M; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Wesley JD; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Granger J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Cracraft J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; O'Brien C; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Perdue N; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Kumar V; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Li S; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Ratliff SS; La Jolla Institute for Immunology, La Jolla, CA, USA.; Roach A; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Misquith A; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Chan CL; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A.; Coppieters K; Project and Alliance Management, Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.; von Herrath M; La Jolla Institute for Immunology, La Jolla, CA, USA matthias@lji.org.; Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark.
Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
Academic Journal
Chodaczek G; Type 1 Diabetes Center, La Jolla Institute for Immunology, La Jolla, CA, USA; Bioimaging Laboratory, Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wroclaw, Poland. Electronic address: grzegorz.chodaczek@port.lukasiewicz.gov.pl.; Pagni PP; Type 1 Diabetes Center, La Jolla Institute for Immunology, La Jolla, CA, USA.; Christoffersson G; Type 1 Diabetes Center, La Jolla Institute for Immunology, La Jolla, CA, USA; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.; Ratliff SS; Type 1 Diabetes Center, La Jolla Institute for Immunology, La Jolla, CA, USA.; Toporkiewicz M; Bioimaging Laboratory, Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wroclaw, Poland.; Wegrzyn AS; Bioimaging Laboratory, Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wroclaw, Poland.; von Herrath M; Type 1 Diabetes Center, La Jolla Institute for Immunology, La Jolla, CA, USA.
Publisher: Academic Press Country of Publication: England NLM ID: 8812164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9157 (Electronic) Linking ISSN: 08968411 NLM ISO Abbreviation: J Autoimmun Subsets: MEDLINE
Editorial & Opinion
Pagni PP; Novo Nordisk Research Center, Seattle, WA, USA.; Wolf A; Novo Nordisk Research Center, Seattle, WA, USA.; Lo Conte M; Novo Nordisk Research Center, Seattle, WA, USA.; Yeh R; Novo Nordisk Research Center, Seattle, WA, USA.; Fu G; Novo Nordisk Research Center, Seattle, WA, USA.; Liu F; Novo Nordisk Research Center, Seattle, WA, USA.; von Herrath M; Novo Nordisk Research Center, Seattle, WA, USA.; Coppieters K; Novo Nordisk A/S Research Projects, Novo Nordisk Park, DK-2760, Måløv, Denmark. kncp@novonordisk.com.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Academic Journal
von Herrath M; Novo Nordisk Research Center Seattle, Inc., Seattle, WA, USA. Electronic address: mtvh@novonordisk.com.; Pagni PP; Novo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.; Grove K; Novo Nordisk Research Center Seattle, Inc., Seattle, WA, USA.; Christoffersson G; Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.; Tang-Christensen M; Novo Nordisk A/S, Måløv, Denmark.; Karlsen AE; Novo Nordisk A/S, Måløv, Denmark.; Petersen JS; Novo Nordisk A/S, Måløv, Denmark.
Publisher: Cell Press Country of Publication: United States NLM ID: 101233170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-7420 (Electronic) Linking ISSN: 15504131 NLM ISO Abbreviation: Cell Metab Subsets: MEDLINE
Academic Journal
Cissé OH; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA ousmane.cisse@nih.gov jkovacs@mail.nih.gov.; Ma L; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Wei Huang D; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Khil PP; Department of Laboratory Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Dekker JP; Department of Laboratory Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Kutty G; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Bishop L; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Liu Y; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Deng X; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.; Hauser PM; Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.; Pagni M; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Hirsch V; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.; Lempicki RA; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.; Stajich JE; Department of Plant Pathology and Microbiology and Institute for Integrative Genome Biology, University of California, Riverside, Riverside, California, USA.; Cuomo CA; Infectious Disease and Microbiome Program, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Kovacs JA; Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA ousmane.cisse@nih.gov jkovacs@mail.nih.gov.
Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE
Academic Journal
Rydén AK; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA; Pacific Northwest Diabetes Research Institute, Seattle, WA, USA.; Perdue NR; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.; Pagni PP; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.; Gibson CB; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.; Ratliff SS; Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.; Kirk RK; Department of Histology and Imaging, Novo Nordisk A/S, Måløv, Denmark.; Friesen TJ; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.; Haase C; Department of Immunopharmacology, Novo Nordisk A/S, Måløv, Denmark.; Coppieters K; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.; von Herrath MG; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA.; Boursalian TE; Type 1 Diabetes R&D Center, Novo Nordisk Inc., Seattle, WA, USA. Electronic address: tbl@novonordisk.com.
Publisher: Academic Press Country of Publication: England NLM ID: 8812164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9157 (Electronic) Linking ISSN: 08968411 NLM ISO Abbreviation: J Autoimmun Subsets: MEDLINE
Academic Journal
Grönholm J; Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID) and Clinical Genomics Program, NIAID, National Institutes of Health, Building 10, Room 11D14, 10 Center Drive, Bethesda, MD, 20814, USA.; Pagni PP; Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA.; La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.; Pham MN; Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA.; Gibson CB; Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA.; Macomber PF; Wellstat Diagnostics, Gaithersburg, MD, USA.; Vela JL; Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA.; von Herrath M; Novo Nordisk Type 1 Diabetes Center, Novo Nordisk Research Center, Seattle, WA, USA.; Lenardo MJ; Molecular Development of the Immune System Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID) and Clinical Genomics Program, NIAID, National Institutes of Health, Building 10, Room 11D14, 10 Center Drive, Bethesda, MD, 20814, USA. lenardo@nih.gov.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Academic Journal
Gill RG; Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO ronald.gill@ucdenver.edu.; Pagni PP; La Jolla Institute for Allergy and Immunology, La Jolla, CA.; Kupfer T; Departments of Surgery and Immunology, University of Colorado Denver, Aurora, CO.; Wasserfall CH; Department of Pathology, University of Florida, Gainesville, FL.; Deng S; Yale University School of Medicine, New Haven, CT.; Posgai A; Department of Pathology, University of Florida, Gainesville, FL.; Manenkova Y; La Jolla Institute for Allergy and Immunology, La Jolla, CA.; Bel Hani A; La Jolla Institute for Allergy and Immunology, La Jolla, CA.; Straub L; Immune Tolerance Network, University of California, San Francisco, San Francisco, CA.; Bernstein P; Immune Tolerance Network, Bethesda, MD.; Atkinson MA; Department of Pathology, University of Florida, Gainesville, FL.; Herold KC; Yale University School of Medicine, New Haven, CT.; von Herrath M; La Jolla Institute for Allergy and Immunology, La Jolla, CA.; Staeva T; JDRF, New York, NY.; Ehlers MR; Immune Tolerance Network, University of California, San Francisco, San Francisco, CA.; Nepom GT; Benaroya Research Institute, Seattle, WA.
Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Pagni PP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어